Staphylococcus aureus as a paradigm of a persistent problem of bacterial multiple antibiotic resistance in Abha, Saudi Arabia

Eastern Mediterranean Health Journal

Volumn 6, Issue 5-6, 2000, Pages 948-954

  Bilal, N E ^a   Gedebou, M ^a  

^a KING KHALID UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; BACTEREMIA; CLASSIFICATION; CROSS INFECTION; HEALTH SURVEY; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PENICILLIN RESISTANCE; PREVALENCE; SAUDI ARABIA; SEROTYPING; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; POPULATION SURVEILLANCE; PREVALENCE; SAUDI ARABIA; SEROTYPING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0034261456     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clinical microbiology reviews, 1993, 6(4):428-42.
2. Speller DCE et al. Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95. Lancet, 1997, 350(9074): 323-5.
3. Lowy FD. Staphylococcus aureus infections. New England journal of medicine, 1998, 339(8):520-32.
4. Thornsberry C. Emerging resistance in clinically important Gram-positive cocci. Western journal of medicine, 1996, 164(1):28-32.
5. Voss A, Doebbeling BN. The worldwide prevalence of methicillin-resistant Staphylococcus aureus. International journal of antimicrobial agents, 1995, 5: 101-6.
6. Kloos WE, Bannerman TL. Staphylococcus and micrococcus. In: Murray PR et al., eds. Manual of clinical microbiology. Washington DC, American Society for Microbiology, 1995:282-98.
7. Woods GL, Washington JA. Antibacterial susceptibility tests: dilution and disk diffusion methods. In: Murray PR et al., eds. Manual of clinical microbiology. Washington DC, American Society for Microbiology, 1995:1327-41.
8. Mulligan ME et al. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. American Journal of medicine, 1993, 94(3):313-28.
9. Ayliffe GAJ. Methicillin-resistant Staphylococcus aureus (MRSA) update. Postgraduate doctor Middle East, 1998, 21: 98-103.
10. Swartz MN. Hospital-acquired infections: diseases with increasingly limited therapies. Proceedings of the National Academy of Sciences of the United States of America, 1994, 91(7):2420-7.
11. Hiramatsu K et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet, 1997, 350(9092): 1670-3.
12. Smith TL et al. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-intermediate Staphylococcus aureus working group. New England journal of medicine, 1999, 340(7):493-501.
13. Sieradzki K et al. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. New England journal of medicine, 1999, 340(7):517-23.
14. Maki DG, Schuna AA. A study of antimicrobial misuse in a university hospital. American journal of the medical sciences, 1978, 275(3):271-82.
15. Visconti JA, Roberts AW. The rational and irrational use of systemic antimicrobial drugs. American journal of hospital pharmacy, 1972, 29(10):828-34.
16. Goldmann DA et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. Journal of the American Medical Association, 1996, 275(3):234-40.